These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17638062)

  • 21. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
    Finsterer J; Voigtländer T; Grisold W
    J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of acute cerebellar ataxia with two possible etiologies: viral cerebellitis and paraneoplastic antibody-positive ovarian cancer.
    Ju H; Lee M; Im K; Kim YH; Kwon KY
    Neurol Sci; 2020 Aug; 41(8):2285-2287. PubMed ID: 32112217
    [No Abstract]   [Full Text] [Related]  

  • 23. Speech and language findings associated with paraneoplastic cerebellar degeneration.
    Paslawski T; Duffy JR; Vernino S
    Am J Speech Lang Pathol; 2005 Aug; 14(3):200-7. PubMed ID: 16229671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraneoplastic cerebellar degeneration with ovarian endometroid carcinoma.
    Jain V; Prabhakar S; Bagga R; Kalra J; Gopalan S
    Acta Obstet Gynecol Scand; 2003 Jul; 82(7):672-3. PubMed ID: 12790851
    [No Abstract]   [Full Text] [Related]  

  • 25. TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration.
    Do LD; Gupton SL; Tanji K; Bastien J; Brugière S; Couté Y; Quadrio I; Rogemond V; Fabien N; Desestret V; Honnorat J
    Cerebellum; 2019 Apr; 18(2):245-254. PubMed ID: 30350014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
    Storstein A; Krossnes BK; Vedeler CA
    Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical paraneoplastic syndrome associated with anti-Yo antibodies.
    Finsterer J; Bodenteich A; Drlicek M
    Clin Neuropathol; 2003; 22(3):137-40. PubMed ID: 12809356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration.
    Eichler TW; Totland C; Haugen M; Qvale TH; Mazengia K; Storstein A; Haukanes BI; Vedeler CA
    PLoS One; 2013; 8(6):e66002. PubMed ID: 23823982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Paraneoplastic subacute cerebellar degeneration: case report].
    Bardy FB; Cagy M; Pompeu Filho F; Lamarca JE; Rabinovitz M; Godoy JM
    Arq Neuropsiquiatr; 2000 Sep; 58(3A):764-8. PubMed ID: 10973125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rehabilitation treatment options for a patient with paraneoplastic cerebellar degeneration.
    Perlmutter E; Gregory PC
    Am J Phys Med Rehabil; 2003 Feb; 82(2):158-62. PubMed ID: 12544763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rare Case of Ovarian Cancer Presenting with Paraneoplastic Cerebellar Degeneration and Limbic Encephalitis.
    Li WH; Cao DY; Shen K; Yang JX
    Chin Med J (Engl); 2015 Oct; 128(19):2685-7. PubMed ID: 26415811
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of Yo Antigen in a Prostatic Adenocarcinoma.
    Rosine N; Chrétien P; Adam C; Beaudonnet G; Not A; Drai J; Vahedi K; Cauquil C; Theaudin M
    Can J Neurol Sci; 2017 Mar; 44(2):221-223. PubMed ID: 28231864
    [No Abstract]   [Full Text] [Related]  

  • 33. Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration.
    Carpenter EL; Vance BA; Klein RS; Voloschin A; Dalmau J; Vonderheide RH
    J Neuroimmunol; 2008 Jan; 193(1-2):173-82. PubMed ID: 18053582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Yo-associated cerebellar syndrome presenting with a brain mass.
    Tüzün E; Bektaş HM; Içöz S; Kürtüncü M; Saip P; Akman-Demir G
    Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):183-4. PubMed ID: 19328621
    [No Abstract]   [Full Text] [Related]  

  • 35. [Paraneoplastic autoimmune syndromes of the nervous system].
    Ashkenazi A; Ovadia H; Abramsky O
    Harefuah; 1999 Nov; 137(9):394-9. PubMed ID: 11419044
    [No Abstract]   [Full Text] [Related]  

  • 36. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration.
    Forgy AP; Ewing TL; Flaningam J
    Gynecol Oncol; 2001 Jan; 80(1):96-8. PubMed ID: 11136578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marantic endocarditis (NBTE) with systemic emboli and paraneoplastic cerebellar degeneration: uncommon presentation of ovarian cancer.
    Singh V; Bhat I; Havlin K
    J Neurooncol; 2007 May; 83(1):81-3. PubMed ID: 17205388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical diagnosis of stage I fallopian tube cancer in anti-Yo antibody paraneoplastic cerebellar degeneration.
    Haggerty AF; Mantia-Smaldone G; Siegelman E; Livolsi V; Tanyi J
    J Obstet Gynaecol; 2015 Jan; 35(1):100-1. PubMed ID: 24960213
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach.
    Kikuchi H; Yamada T; Okayama A; Hara H; Taniwaki T; Shigeto H; Sasaki M; Iwaki T; Kira J
    Fukuoka Igaku Zasshi; 2000 Apr; 91(4):104-9. PubMed ID: 10826224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.